Year: 2019

December 1, 2019Chicago, U.S. and Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today revealed its industry-leading enterprise imaging portfolio comprising innovative digital imaging platforms, advanced informatics and a suite of services at the 2019 Radiological Society of North America Annual Meeting (RSNA). With a focus on optimizing image acquisition, viewing and data interpretation, and diagnostic patient management workflows, Philips is providing flexible and scalable enterprise imaging solutions to hospitals and imaging centers as they seek to step up their performance by simultaneously improving the patient experience, health outcomes, and staff experience, while lowering the cost of care.With comprehensive enterprise imaging capabilities at its foundation, at RSNA Philips...

MEDDELELSE NR. 180 ChemoMetec har over en årrække opnået en betydelig fremdrift, og såvel omsætningen som driftsindtjeningen er øget markant. Det er afgørende for bestyrelsen at sikre de bedste rammer og forudsætninger for den fortsatte udvikling af ChemoMetec og eksekveringen af strategien. Bestyrelsen har derfor fundet det nødvendigt at styrke den daglige ledelse og har udpeget Steen Søndergaard som ny CEO.Bestyrelsesformand i ChemoMetec, Preben Kønig, udtaler om ledelsesskiftet: ”Det er i den seneste tid blevet klart for bestyrelsen, at det ikke er foreneligt med selskabets interesser at have en CEO, som er bosat uden for Danmark. Bestyrelsen ønsker en højere grad af daglig tilstedeværelse på hovedkontoret i Allerød og ligeledes en større involvering i den daglige drift. Det er samtidig vigtigt at understrege, at ændringen i ledelsen...

December 1, 2019Comprehensive platform launching with an ecosystem of applications from partners including Aidoc, MaxQ AI, Quibim, Riverain Technologies and Zebra MedicalChicago, U.S. and Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of IntelliSpace AI Workflow Suite [1] to enable healthcare providers to seamlessly integrate AI applications into the imaging workflow. Part of Philips’ new enterprise imaging informatics solution, the comprehensive AI workflow platform provides a full suite of applications for integration and centralized workflow management of AI algorithms, delivering structured results wherever they’re needed across the healthcare enterprise. Partners at launch include Aidoc, MaxQ AI, Quibim [2], Riverain Technologies and Zebra Medical.IntelliSpace...

December 1, 2019Scalable, flexible solution embeds intelligence and analytics across clinical and operational workflowsChicago, U.S. and Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced its next-generation enterprise imaging solution. The introduction follows several years of strategic investments in R&D and complementary acquisitions, resulting in a suite of integrated products that deliver a comprehensive platform designed to connect clinical capabilities and optimize workflows around every step in the patient’s journey. The new solution is being unveiled at the 2019 Radiological Society of North America (RSNA) Annual Meeting.“Our new solution seamlessly embeds intelligence at every step of each operational workflow and disease pathway, providing the foundation...

Tórshavn, Faroe Islands, 2019-11-30 (GLOBE NEWSWIRE) — P/F Atlantic Petroleum (NASDAQ Copenhagen: ATLA DKK & Oslo Stock Exchange: ATLA NOK) announces that the standstill Agreement with London Oil and Gas Limited in Administration (LOG) to 30th November, announced 23rd July, 2019 is extended to 31st January 2020.Extension of standstillLOG have agreed to extend the Standstill Agreement dated 23rd July 2019 from 30th November 2019 to 31st January 2020. The Board of Atlantic Petroleum is working on refinancing its activities for 2020 and onwards. The market will be informed of the results of these efforts in due course.Atlantic Petroleum expects to have positive cashflow from its activities in 2020.Orlando OverviewThe Company has retained an economic interest in the Orlando Field; sold in 2017 to Decipher Energy. Under the Sale...

OVERVIEW OF ECONOMIC ACTIVITIESPRFoods’ sales of 1st quarter 2019/2020 financial year was 19.3 million euros. Net profit 0.57 million euros, four times higher than Q3/2018. EBITDA 1.47 million euros, growth 31%.MANAGEMENT COMMENTARYWe are happy to announce that based on the first quarter of the financial year (3rd quarter of 2019) the restructuring processes commenced within the Group during the last financial year, are demonstrating positive results.The reporting period was characterized by a general decline in the prices of raw materials of fishery products, resulting in a fall in the prices of fish, fish fillets and smoked products. In spite of the approximately 5% price drop of the Group’s main products, we were able to keep the total sales practically at the level of the last year. The third quarter sales for 2019 totalled...

AS- i PRFoods 2019/2020. majandusaasta 1. kvartali müügikäive oli 19,3 miljonit eurot  ning puhaskasum 0,57 miljonit eurot, mis kasvas ligi neli korda võrreldes eelmise aasta sama perioodiga. EBITDA kasvas 31% 1,47 miljoni euroni.JUHTKONNA KOMMENTAARHea meel on tõdeda, et käesoleva finantsaasta esimese kvartali (2019. aasta 3. kvartal) põhjal võime öelda, et eelmisel majandusaastal Grupis alustatud ümberkorraldused on andnud positiivseid tulemusi.Aruandeperioodi iseloomustas üldine kalatoodete tooraine hindade langus, millest tulenevalt langesid nii kala- ja kalafilee kui suitsutatud toodete hinnad. Vaatamata Grupi põhitoodete ca 5%-lisele hinnalangusele, suutsime kogukäibe hoida eelmise aastaga pea samal tasemel. 2019. aasta 3. kvartali müügikäive oli 19,33 miljonit eurot (3. kv 2018: 19,39 miljonit eurot).Grupi konsolideeritud EBITDA...

BOUSSARD & GAVAUDAN HOLDING LIMITEDNovember 2019 TRANSACTION IN OWN SECURITIES ACTIVITY REPORT129 November 2019For further information please contact:Boussard & Gavaudan Investment Management, LLPEmmanuel Gavaudan (London) +44 203 751 5389François-Xavier Baud (London) +44 203 751 5395The Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the “Shares”) are listed on Euronext Amsterdam. The Shares...

BOUSSARD & GAVAUDAN HOLDING LIMITEDNovember 2019 TRANSACTION IN OWN SECURITIES ACTIVITY REPORT129 November 2019For further information please contact:Boussard & Gavaudan Investment Management, LLPEmmanuel Gavaudan (London) +44 203 751 5389François-Xavier Baud (London) +44 203 751 5395The Company is established as a closed-ended investment company domiciled in Guernsey. The Company has received the necessary approval of the Guernsey Financial Services Commission and the States of Guernsey Policy Council. The Company is registered with the Dutch Authority for the Financial Markets as a collective investment scheme pursuant to article 2:73 in conjunction with 2:66 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). The shares of the Company (the “Shares”) are listed on Euronext Amsterdam. The Shares...

CALGARY, Alberta, Nov. 30, 2019 (GLOBE NEWSWIRE) — Cuda Oil and Gas Inc. (“Cuda” or the “Company”) (TSXV: CUDA) is pleased to announce its financial and operating results for the three and nine months ended September 30, 2019.  The unaudited interim condensed consolidated financial statements and related management’s discussion and analysis (“MD&A”) are available under the Company’s profile on the SEDAR website at www.sedar.com.  Selected financial and operating information for the three and nine months ended September 30, 2019 appear below and should be read in conjunction with the related financial statements and MD&A.Financial and Operational Results(1)Notes:(1) Results related to the sale of the Company’s oil and gas assets and related decommissioning liabilities in Quebec, Canada, (the “Quebec Assets”),...